tert-Butyl 4-bromo-2-fluorobenzoate

Intermediate for Venetoclax. Venetoclax (trade name Venclexta) is a small molecule oral drug that treats chronic lymphocytic leukemia (CLL) in those with a specific chromosomal abnormality. Venetoclax is a BH3-mimetic and acts as a Bcl-2 inhibitor. Venetoclax has been approved by US FDA om April 11, 2016.

Specifications

Product Name:                  tert-Butyl 4-bromo-2-fluorobenzoate

Synonyms:                         N/A

CAS Number:                     889858-12-2

Molecular Weight:            275.117

Molecular Formula:          C11H12BrFO2

Purity (HPLC):                     ≥95%

Shipping Conditions:         Room temperature.

Storage Conditions:           Refrigerated.

Regulatory Statement:      For Research Use Only.

SMILES:                               Brc1ccc(c(c1)F)C(=O)OC(C)(C)C

tert-Butyl 4-bromo-2-fluorobenzoate

  • $138.00
  • Ex Tax: $138.00

Available Options